Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Neurology and Neuroscience Reports|November 22, 2021
Brain Cancers in Genetic SyndromesEdina Komlodi-Pasztor, Jaishri O Blakeley
The Oncologist|November 15, 2024
Immunotherapy benefits for large brain metastases in non-small cell lung cancerNarayanan Sadagopan, Edina Komlodi-Pasztor, Irina Veytsman
Nature Reviews. Clinical Oncology|February 2, 2011
Mitosis is not a key target of microtubule agents in patient tumorsEdina Komlodi-Pasztor, Dan Sackett, Julia Wilkerson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 5, 2012
Inhibitors targeting mitosis: tales of how great drugs against a promising target were brought down by a flawed rationaleEdina Komlodi-Pasztor, Dan L Sackett, Antonio Tito Fojo
Current Oncology Reports|May 11, 2022
Diagnosis and Management of Stroke in Adults with Primary Brain TumorEdina Komlodi-Pasztor, Mark R Gilbert, Terri S Armstrong
Cell Cycle (Georgetown, Tex.)|February 16, 2012
Retained platinum uptake and indifference to p53 status make novel transplatinum agents active in platinum-resistant cells compared to cisplatin and oxaliplatinRobert F Murphy, Edina Komlodi-Pasztor, Robert Robey, et al.
CNS Oncology|March 8, 2024
Postradiation platinum-etoposide in adult medulloblastomas: retrospective analysis of hematological toxicityEdina Komlodi-Pasztor, Vasu Munjapara, Charles G Eberhart, et al.
Cell Cycle (Georgetown, Tex.)|September 9, 2011
Schedule-dependent synergy of histone deacetylase inhibitors with DNA damaging agents in small cell lung cancerVictoria L Luchenko, Crystal D Salcido, Yongwei Zhang, et al.
Clinical Trials (London, England)|October 31, 2023
Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trialsR Taylor Sundby, Steven D Rhodes, Edina Komlodi-Pasztor, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2015
Microtubule-targeting agents augment the toxicity of DNA-damaging agents by disrupting intracellular trafficking of DNA repair proteinsMarianne S Poruchynsky, Edina Komlodi-Pasztor, Shana Trostel, et al.
Pageof 2